Procurement of Chemotherapy and Supportive Care Medications for Indian Army

Work Description - NA

This tender is being issued by the Department of Military Affairs, under the Ministry of Defence, for the procurement of a comprehensive range of high-value pharmaceutical supplies essential for critical medical applications. The Indian Army, through its office in Kolkata, is seeking bids for a significant quantity of various chemotherapy and supportive care medications. The tender, identified by Bid Number GEM/2026/B/7835071, encompasses a diverse list of items including Cyclophosphamide (500 mg Inj), Cytosine Arabinoside (preservative-free 100 mg Inj and 500 mg Inj), Dacarbazine (200mg Inj), Doxorubicin HCl (Inj 2mg/ml, 25 ml Inj), Fludarabine (50 mg Inj), Hydroxyurea (500 mg Cap), Idarubicin (5mg/ml Inj), Melphalan (50mg Inj), Methotrexate (15mg preservative-free 3 ml Inj), Vincristine Sulphate (1mg Inj), Thalidomide (50mg Tab), Granulocyte Colony Stimulating Factor (300mcg Inj), Lenolidamide (25mg Tab), Lenalidomide (10 mg Cap), Zoledronic Acid (5 mg Inj and 4mg powder for Inj), Dasatinib (50 mg Tab), and Azacytidine (100 mg Inj). The total required quantity for these vital medications amounts to 95,063 units. Interested parties are invited to submit their bids, with the bidding period commencing on August 18, 2026, at 3:03 PM and concluding on September 1, 2026, at 3:00 PM.